Today, UltraSight announced the findings from a landmark pivotal study that confirms its AI guidance technology enables novice ultrasound users to acquire high-quality diagnostic images of the 10 standard cardiac views.
News | Cardiac Imaging
New Landmark Study Indicates UltraSight Enables Novice Ultrasound Users to Capture High Quality Cardiac Images

November 28, 2022 – UltraSight, an Israeli-based digital health pioneer transforming cardiac imaging through the power ...

Home November 28, 2022
Home
Published online November 8 in the journal, Radiology, the study enabled the visualization of pulmonary hemodynamics and perfusion with high sensitivity, specificity and diagnostic accuracy, and without the use of contrast media
News | Cardiac Imaging
Study Reports Similar Efficacy of Dynamic Digital Radiography of the Chest with Lung Ventilation Perfusion for Detection of Chronic Thromboembolic Pulmonary Hypertension

November 28, 2022 — Konica Minolta Healthcare Americas, Inc., a leader in medical diagnostic imaging and healthcare ...

Home November 28, 2022
Home
Survivors face higher risk of cardiac events that can reduce their life expectancy by decades
News | Coronavirus (COVID-19)
Study Finds That Risk of Myocarditis After SARS-CoV-2 Vaccination is Increased But Very Low

November 25, 2022 — A large study found that myocarditis after SARS-CoV-2 vaccination was rare but higher in younger ...

Home November 25, 2022
Home
Left: Echocardiogram at birth shows severe non-delamination of the tricuspid valve septal leaflet, with coaptation point near the right ventricle apex (marked with arrow). The right ventricle is small, while the right atrium is large. Right: Jaxon’s echocardiogram today shows a normal tricuspid valve position (marked with arrow) and normal sizes of the right atrium and right ventricle.
News | Pediatric Cardiology
From Severe Ebstein Anomaly to a Normal Heart

November 25, 2022 — Jodie Votava-Smith, MD, has pulled up two side-by-side echocardiograms on her computer screen and is ...

Home November 25, 2022
Home
The Cardiovascular Research Foundation has announced its Inaugural Pulse‑Setter Awards, including Pulse-setter Champion and Women as One Co-Founder, Roxana Mehran, MD.
News | Cardiovascular Education
Women as One Co-Founder Among Four to Receive Inaugural CRF Awards

November 23, 2022 — The Cardiovascular Research Foundation (CRF) has announced its inaugural Pulse‑Setter Awards ...

Home November 23, 2022
Home
Validates the Viz Aortic Dissection Detection algorithm with high sensitivity, specificity and positive predictive value
News | Artificial Intelligence
Viz.ai Announces Positive New Data From Large Aortic Dissection AI Real-World Study at the 2022 VEITHsymposium

November 23, 2022 — Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today ...

Home November 23, 2022
Home
Nicholas Pajewski, Ph.D., associate professor of biostatistics and data science at Wake Forest University School of Medicine. Credit: Wake Forest University School of Medicine
News | Hypertension
Study Highlights Importance of Long-term Management of Hypertension

November 23, 2022 — In 2015, published findings from the landmark Systolic Blood Pressure Intervention Trial (SPRINT) ...

Home November 23, 2022
Home
Survivors face higher risk of cardiac events that can reduce their life expectancy by decades
News | Pediatric Cardiology
Exercise Testing Detects Silent Cardiovascular Dangers Common in Pediatric Cancer Survivors

November 23, 2022 — Cardiopulmonary exercise testing (CPET) can detect underlying early signs of cardiovascular problems ...

Home November 23, 2022
Home
New research by Cedars-Sinai investigators supports evidence that social factors, such as unemployment, financial difficulties, racial discrimination and other stressors, affect an individual's health. Getty Images
News | Stroke
Racism, Stress and Stroke Outcomes

November 22, 2022 — investigators from the Department of Neurology at Cedars-Sinai have new information on stroke ...

Home November 22, 2022
Home
Trial Evaluates FDA-Designated Breakthrough Therapy for Patients Who Lack Treatment Options
News | Heart Failure
Impulse Dynamics Announces First Patient Enrolled in AIM HIGHer — Implantable Device Trial to Treat Heart Failure in Higher EF Population

November 22, 2022 — Impulse Dynamics, a global medical device company dedicated to improving the lives of people with ...

Home November 22, 2022
Home
CroíValve has announced the successful First in Human implants of its DUO Tricuspid Coaptation Valve technology for the treatment of Tricuspid Regurgitation as part of its TANDEM I study in Poland.
News | Heart Valve Technology
CroíValve Reports Successful First in Human Implants of its DUO Tricuspid Coaptation Valve System

November 22, 2022 — CroíValve has announced the successful First in Human implants of its DUO Tricuspid Coaptation Valve ...

Home November 22, 2022
Home
Successfully Met Primary and Secondary Endpoints, with Mean Placebo-Adjusted Reduction in Systolic Blood Pressure of 9.7 mmHg in Uncontrolled and Resistant Hypertensive Subjects at 50 mg Once Daily (p=0.01 vs. placebo)
News | Hypertension
Mineralys Therapeutics Announces Positive Topline Phase 2 Data for MLS-101 in the Target-HTN Trial Evaluating the Treatment of Uncontrolled and Resistant Hypertension

November 21, 2022 — Mineralys Therapeutics, Inc., a private, clinical-stage biopharmaceutical company committed to ...

Home November 21, 2022
Home
UH Cleveland Medical Center. Image courtesy of University Hospitals
News | Deep Vein Thrombosis (DVT)
Four Prospective, Multicenter Studies Support Use of Drug-Coated Balloons Over Bare Metal Stents in Treating Femoropopliteal Lesions

November 21, 2022 — New research published in the Journal of the American College of Cardiology shows the use of drug ...

Home November 21, 2022
Home
Artificial intelligence can improve diagnosis and treatment for patients, but first the AI-enabled clinical tools have to be easily available and used.
News | Artificial Intelligence
High adopters of AI-enabled screening tool are more likely to diagnose left ventricular dysfunction than low adopters, Mayo Clinic study finds

November 21, 2022 — Artificial intelligence can improve diagnosis and treatment for patients, but first the AI-enabled ...

Home November 21, 2022
Home
Successfully Met Primary and Secondary Endpoints, with Mean Placebo-Adjusted Reduction in Systolic Blood Pressure of 9.7 mmHg in Uncontrolled and Resistant Hypertensive Subjects at 50 mg Once Daily (p=0.01 vs. placebo)
News | Hypertension
Mineralys Therapeutics Announces Positive Topline Phase 2 Data for MLS-101 in the Target-HTN Trial Evaluating the Treatment of Uncontrolled and Resistant Hypertension

November 21, 2022 — Mineralys Therapeutics, Inc., a private, clinical-stage biopharmaceutical company committed to ...

Home November 21, 2022
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now